Aribio Lab Sets Record Date for Extraordinary General Meeting with No Dilution or Capital Impact

Aribio Lab sets July 7, 2026 as the record date to determine shareholders entitled to attend the extraordinary general meeting.
This is a routine closure of the shareholder register following a board resolution, involving no capital change or new share issuance.
The disclosure is a procedural step for convening the shareholders meeting and does not affect existing shareholders' stake or stock value.
No treasury stock acquisition, cancellation, or dividend payout is included in this disclosure.
[AI Summary]Aribio Lab's record date setting is a routine procedural step for shareholder determination with no capital or governance changes, resulting in a neutral impact on shareholder value.